"The U.S. Food and Drug Administration today approved Ragwitek, the first allergen extract administered under the tongue (sublingually) to treat short ragweed pollen induced allergic rhinitis (hay fever), with or without conjunctivitis (eye inflam"...
(Generic versions may still be available.)
Livostin Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Livostin (levocabastine hydrochloride) is an antihistamine eye drop used to treat symptoms of eye allergies, such as inflammation, itching, watering, and burning. Livostin is no longer available in the U.S., but generic versions may be available. Common side effects include burning, stinging, itching, or watering of the eyes, blurred vision, dry or puffy eyes, headache, nausea, or fatigue.
The recommended dosage of Livostin is 1 drop into affected eye(s), as directed by your doctor. Livostin contains a preservative (benzalkonium chloride), so do not wear contact lenses during treatment. Livostin may interact with other eye drops. Tell your doctor all medications and supplements you take. Livostin should be used during pregnancy only if clearly needed. Livostin passes into breast milk. Consult your doctor before breastfeeding.
Our Livostin (levocabastine hydrochloride) Side Effects Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information Overview?
A concise overview of the drug for the patient or caregiver from First DataBank.
Livostin Overview - Patient Information: Side Effects
In the US -
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Read the entire patient information overview for Livostin (Levocabastine)»
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Livostin FDA Prescribing Information: Side Effects
The most frequent adverse experiences reported with the use of LIVOSTIN™ 0.05% (levocabastine hydrochloride ophthalmic suspension) were mild, transient stinging and burning (29%) and headache (5%).
Other adverse experiences reported in approximately 1-3% of patients treated with LIVOSTIN™ were visual disturbances, dry mouth, fatigue, pharyngitis, eye pain/dryness, somnolence, red eyes, lacrimation/discharge, cough, nausea, rash/erythema, eyelid edema, and dyspnea.
Read the entire FDA prescribing information for Livostin (Levocabastine) »
Additional Livostin Information
Livostin - User Reviews
Livostin User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.